1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Osteoarthritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de la Cruz, C; de Nicoläs, R; Egido, J; González, E; Herrero-Beaumont, G | 1 |
| Battaglia, E; Camussi, G; Lupia, E; Modena, V; Montrucchio, G | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Osteoarthritis
| Article | Year |
|---|---|
Long-term effect of nonsteroidal anti-inflammatory drugs on the production of cytokines and other inflammatory mediators by blood cells of patients with osteoarthritis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Diclofenac; Dinoprostone; Double-Blind Method; Female; Humans; Interleukin-1; Interleukin-6; Knee Joint; Leukotriene B4; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Osteoarthritis; Platelet Activating Factor; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 1994 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Osteoarthritis
| Article | Year |
|---|---|
Role of tumor necrosis factor-alpha and platelet-activating factor in neoangiogenesis induced by synovial fluids of patients with rheumatoid arthritis.
Topics: Animals; Arthritis, Rheumatoid; Collagen; Disease Models, Animal; Drug Combinations; Female; Humans; Laminin; Male; Mice; Mice, Inbred C57BL; Middle Aged; Neovascularization, Pathologic; Osteoarthritis; Platelet Activating Factor; Proteoglycans; Synovial Fluid; Tumor Necrosis Factor-alpha | 1996 |